Dr Caia Dominicus
Caia is a Postdoctoral Fellow with the Open Targets Initiative at the Sanger Institute
Caia’s current research is focused on the development of a screening platform that will facilitate the systematic phenotypic and transcriptomic comparison of mutations of different genetic risk factors contributing to Alzheimers disease, Parkinson’s disease and Amyotropic Lateral Sclerosis. Caia obtained her PhD at the Cambridge Institute for Medical Research with Stefan Marciniak where she studied the role of the unfolded protein response in early development. She then moved to the laboratory of Moritz Treeck at the Francis Crick Institute for her post-doctoral studies where she developed a genome-wide arrayed CRISPR platform for targeted screening in Toxoplasma gondii, and undertook global phosphoproteomic profiling studies to investigate T. gondii egress signalling pathways.
Postdoctoral Research Fellow at the Sanger Institute (Open Targets Intitiative)
Postdoctoral Research Fellow at the Francis Crick Institute
PhD Biomedical Research, University of Cambridge
MSc Molecular Biology of Infectious Diseases, London School of Hygiene and Tropical Medicine
BSc Biology, Imperial College London